The Federal Government has trained scientists drawn from key research institutions across the country on mRNA technology ...
The appointment of a fervent vaccine opponent — Robert F. Kennedy Jr. — as secretary of the Department of Health and Human ...
In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...
This article explores how single-cell multiomics and spatial transcriptomics are illuminating early pregnancy, uncovering ...
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
A new generation of aging tests is moving out of specialist labs and into everyday life, promising to tell you how old your ...
T his past year, we explored a lot of new cell biology research—from cancer to plants to microbes, and more! It’s hard to ...
A research team at the University of California, Davis, has shown that cabernet sauvignon vines carry stable epigenetic ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...
As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.
University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene ...